Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ANDAs To Include Six Months Of Stability Test Data Under FDA Draft Guidance

Executive Summary

The agency advises sponsors to follow the stability testing recommendations in the International Conference on Harmonization guidances; three companies submit comments seeking clarification from FDA.

You may also be interested in...



ANDA Sponsors Get Some Relief on New Stability Requirements

FDA still expects rush of ANDA submissions before new stability requirements take effect June 20, but agency has eliminated some tests and reduced some batch sizes in response to industry comments.

ANDA Sponsors Get Some Relief On New Stability Requirements

FDA still expects rush of ANDA submissions before new stability requirements take effect June 20, but agency has eliminated some tests and reduced some batch sizes in response to industry comments.

Generic 180-Day Exclusivities Might Be Imperiled By ANDA Stability Guidance

Industry experts predict generic company pushback on some aspects of Q&A draft guidance and worry about unintended consequences, including impact on drug master files.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS054860

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel